Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Capital Reinvestment Ratio
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Capital Reinvestment Ratio of 2.35x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥18.31 Million) in capital expenditures (CN¥43.04 Million). See 300497 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangxi Fushine Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Jiangxi Fushine Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check Jiangxi Fushine Pharmaceutical Co Ltd (300497) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see Jiangxi Fushine Pharmaceutical Co Ltd (300497) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.59x | CN¥62.67 Million | CN¥224.88 Million | ▲ +375.0% |
| 2024 | 0.76x | CN¥187.64 Million | CN¥141.75 Million | ▼ -92.0% |
| 2021 | 9.40x | CN¥72.32 Million | CN¥679.60 Million | ▲ +699.8% |
| 2020 | 1.17x | CN¥382.35 Million | CN¥449.24 Million | ▲ +22.2% |
| 2019 | 0.96x | CN¥337.91 Million | CN¥324.90 Million | ▲ +3.2% |
| 2018 | 0.93x | CN¥175.91 Million | CN¥163.89 Million | ▲ +98.3% |
| 2017 | 0.47x | CN¥210.72 Million | CN¥98.99 Million | ▲ +8.9% |
| 2016 | 0.43x | CN¥188.53 Million | CN¥81.34 Million | ▼ -56.7% |
| 2015 | 1.00x | CN¥74.01 Million | CN¥73.74 Million | ▼ -39.7% |
| 2014 | 1.65x | CN¥31.39 Million | CN¥51.86 Million | ▲ +25.0% |
| 2013 | 1.32x | CN¥57.22 Million | CN¥75.60 Million | ▲ +62.9% |
| 2012 | 0.81x | CN¥63.20 Million | CN¥51.24 Million | ▼ -66.7% |
| 2011 | 2.43x | CN¥33.80 Million | CN¥82.21 Million | — |